FLVCR2 and cancer: While CCT may contribute to the correct folding of wild type p53, how its increased expression in cancer cells supports the mutant or unfolded forms of p53 remains to be determined but could involve interactions with other proteins like MDM2 or PTMs that modify CCT activity.